{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","summary":"Teva Pharmaceutical Industries is a biopharmaceutical company with a world-class generics business, operating across three segments: United States, Europe, and International Markets. It markets over 350 generic prescription products, innovative medicines including AUSTEDO (deutetrabenazine), AJOVY (fremanezumab), UZEDY (risperidone), and COPAXONE (glatiramer acetate), as well as biosimilars such as TRUXIMA, SELARSDI, and EPYSQLI. Teva also provides API, contract manufacturing, and distribution services through its Anda business unit.","people":[],"products":[{"name":"AUSTEDO / AUSTEDO XR","type":"service","description":"Deutetrabenazine tablets for Huntington's disease chorea and tardive dyskinesia."},{"name":"AJOVY","type":"service","description":"Fremanezumab injection for preventive treatment of migraine in adults and children aged 6-17."},{"name":"UZEDY","type":"service","description":"Risperidone extended-release injectable suspension for schizophrenia and bipolar 1 disorder in adults."},{"name":"COPAXONE","type":"service","description":"Glatiramer acetate injection for treatment of relapsing forms of multiple sclerosis."},{"name":"TRUXIMA","type":"service","description":"Rituximab-abbs biosimilar injection for Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia."},{"name":"BENDEKA","type":"service","description":"Bendamustine HCl liquid formulation for CLL and indolent B-cell NHL, licensed from Eagle Pharmaceuticals."},{"name":"SELARSDI","type":"service","description":"Ustekinumab-aekn biosimilar injection, recently launched."},{"name":"EPYSQLI","type":"service","description":"Eculizumab-aagh biosimilar, recently launched."},{"name":"SUDOCREM","type":"service","description":"OTC global brand marketed in the Europe segment."},{"name":"Anda","type":"platform","description":"U.S. distribution business for generic, biosimilar, innovative, and OTC pharmaceutical products."}],"partnerships":[{"partner_name":"Eagle Pharmaceuticals","partnership_type":"licensing","description":"Teva licensed BENDEKA (bendamustine HCl) from Eagle Pharmaceuticals for CLL and NHL treatment.","start_date":null},{"partner_name":"Sanofi","partnership_type":"development","description":"Phase 3 programs for duvakitug (anti-TL1A) in ulcerative colitis and Crohn's disease initiated by Sanofi and Teva in October 2025.","start_date":null},{"partner_name":"Takeda","partnership_type":"strategic","description":"Teva held 51% of Teva-Takeda business venture in Japan; divested on March 31, 2025.","start_date":null},{"partner_name":"Medis","partnership_type":"strategic","description":"Teva affiliate offering out-licensing platform with portfolio of products to other pharmaceutical companies.","start_date":null}],"affiliations":[],"origin":{"leaf":"a6af8c8bc7a5cf05ec2a85190612838baef7794bab478175cddb6ca7b0052aa6","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"820a7008f8b8ea5a3a8006d9140c57557e692c072767b1c31da83bdd7f05e749","parent":"580c7077a736ca43237d3a4bf14f9963c72394a957e6e1532816736917034b57","source":"0001193125-26-034532","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}